top of page

About Dr. Soroush Sohrabi

Dr. Soroush Sohrabi is a distinguished senior vascular and endovascular consultant and phlebologist, specialising in the treatment of venous conditions and a broad range of vascular disorders.

Trained in England, he earned his Certificate of Completion of Training (CCT) and further enhanced his expertise through prestigious fellowships in the USA and Australia, focusing on cutting-edge vascular techniques.

In addition to his clinical expertise, Dr. Soroush is a certified vascular sonographer, having completed specialised training at the University of Leeds, England. This allows him to provide precise, high-quality vascular diagnostics using advanced ultrasound imaging.

A dedicated academic, he previously served as an Academic Clinical Lecturer in Vascular Surgery with the National Institute for Health and Care Research (NIHR) in England. His research contributions include 28 publications in leading medical and surgical journals. He is also the recipient of the prestigious Medawar Medal for his outstanding PhD research in the UK.

His leadership experience includes serving as the Clinical Director of a major vascular surgery unit in Wales, UK, where he played a key role in improving vascular care services.

Dr. Soroush Sohrabi is currently practising at Liv Hospital City Walk, Dubai, treating both arterial and venous disorders using the latest technologies in a multidisciplinary environment.

Dubai-vein-specialist-Dr-Soroush-mission-.jpg

Mission

Varicose veins are a prevalent condition, affecting approximately one-third of the adult population.

While often perceived as a cosmetic concern, varicose veins can lead to significant health complications, including pain, swelling, skin changes, and, in severe cases, venous ulcers.

Beyond physical health, the visible nature of varicose veins can also impact an individual's confidence and quality of life.

Our mission is to empower individuals by enhancing their understanding of this common condition, raising awareness about its potential health implications, providing effective treatment options, and ensuring comprehensive follow-up care. By offering personalised education and support, we aim to improve both the physical well-being and self-esteem of those affected by varicose veins.

Dr. Soroush Sohrabi in the news

Dr. Soroush Sohrabi Publications

  1. SHOCkwave lithotripsy for patients with peripheral arterial disease: the SHOCC study, Journal of Vascular Society of Great Britain and Ireland, 2024;3(3):140-146

  2. The SHOCC study: SHOCKwave lithotripsy for patients with peripheral arterial disease, European journal of vascular and endovascular surgery, 2023 Nov;6(5): e69

  3. Cardiovascular risk in patients with small and medium abdominal aortic aneurysms, and no history of cardiovascular disease. British Journal of Surgery. 2014 Sep; 101(10):1238-43

  4. Diabetic foot and diabetic foot debridement technique, Surgery Journal, 2014 Sep, 32(10):491-95

  5. Carotid-femoral pulse wave velocity is negatively correlated with aortic diameter. Hypertension research. 2014 Oct;37(10):926-32

  6. A variant in LDLR is associated with abdominal aortic aneurysm. Circulation: Cardiovascular Genetics. 2013 Oct;6(5):498-504

  7. Exploring smooth muscle phenotype and function in a bioreactor model of abdominal aortic aneurysm. Journal of translational medicine, 2013 Sep 12; 11(1):208.

  8. Plasma thrombin-antithrombin complex, prothrombin fragments 1 and 2, and D-dimer levels are elevated after endovascular but not open repair of infrarenal abdominal aortic aneurysm. Journal of Vascular Surgery. 2013 Jun;57(6):1512-8.

  9. A sequence variant associated with sortilin-1 (SORT1) on 1p13.3 is independently associated with abdominal aortic aneurysm. Human molecular genetics. 2013 2013-Jul-15;22(14):2941-7.

  10. Ankle pressures in UK South Asians with diabetes mellitus: a case control study. Heart. 2013 May;99(9):614-9.

  11. Quality and readability of online patient information for abdominal aortic aneurysms. Journal of Vascular Surgery. 2012 Jul;56(1):21-6.

  12. Implantable versus cuffed external central venous catheters for the management of children and adolescents with acute lymphoblastic leukaemia. Pediatric Surgery International. 2012 Dec;28(12):1195-9.

  13. Calcium channel blockers enhance sac shrinkage after endovascular aneurysm repair. Journal of Vascular Surgery. 2012 Jun;55(6):1593-9.

  14. Clot Architecture Is Altered in Abdominal Aortic Aneurysms and Correlates With Aneurysm Size. Arteriosclerosis Thrombosis and Vascular Biology. 2011 Dec;31(12):3004-10.

  15. Abdominal Aortic Aneurysm Is Associated with a Variant in Low-Density Lipoprotein Receptor-Related Protein 1. American Journal of Human Genetics. 2011 Nov 11;89(5):619-27.

  16. Securing the aorta for organ perfusion in donation after cardiac death donors; novel techniques and a cautionary tale. Transplant International. 2009 Aug;22(8):856-7.

  17. Peritoneal Cooling May Provide Improved Protection for Uncontrolled Donors After Cardiac Death: An Exploratory Porcine Study. American Journal of Transplantation. 2009 Jun;9(6):1317-23.

  18. Machine perfusion or cold storage in deceased-donor kidney transplantation. The New England journal of medicine. 2009 2009-Apr-2;360(14):1461-0; author reply

  19. Dual transplantation of marginal kidneys from nonheart beating donors selected using machine perfusion viability criteria. Journal of Urology. 2008 Jun;179(6):2305-9.

  20. Evaluation of the ischemic protection efficacy of a laparoscopic renal cooling device using renal transplantation viability assessment criteria in a porcine model. Journal of Urology. 2008 Mar;179(3):1184-9.

  21. Donor risk factors for renal graft thrombosis. Transplantation Proceedings. 2007 Jan-Feb;39(1):138-9.

  22. Donation after cardiac death kidneys with low severity pre-arrest acute renal failure. American Journal of Transplantation. 2007 Mar;7(3):571-5.

  23. Diabetic donors as a source of non-heart-beating renal transplants. Transplantation Proceedings. 2006 Dec;38(10):3402-3.

  24. Dual renal transplantation for kidneys from marginal non-heart-beating donors. Transplantation Proceedings. 2006 Oct;38(8):2633-4.

  25. Renal transplants from category III non-heart-beating donors with evidence of pre-arrest acute renal failure. Transplantation Proceedings. 2006 Oct;38(8):2635-6.

  26. Agonal period in potential non-heart-beating donors. Transplantation Proceedings. 2006 Oct;38(8):2629-30.

  27. Renal graft function after prolonged agonal time in non-heart-beating donors. Transplantation Proceedings. 2006 Dec;38(10):3400-1.

  28. Non-heart-beating kidney transplantation: 6-Year outcomes. Transplantation Proceedings. 2006 Dec;38(10):3396-7.

bottom of page